Tamiflu

Product NDC: 50090-0662
11-digit product format: 500900662
Labeler code: 50090
Product ID: 50090-0662_40112622-f4e9-440b-b005-8a5a0d1d7e29
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: oseltamivir phosphate
Dosage form: CAPSULE
Route: ORAL
Labeler: A-S Medication Solutions
Application: NDA021087
Marketing category: NDA
Marketing start: 1999-10-27
Marketing end: 0000-00-00
Substance: OSELTAMIVIR PHOSPHATE
Active strength: 75 mg/1
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	50090-0662		D	Discontinued by firm		2026-08-17
excluded package	package	50090-0662	50090-0662-0	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-0662-0	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-0662-0	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50090-0662-0	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50090-0662-0	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50090-0662-0	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50090-0662-0	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50090-0662-0	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50090-0662-0	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50090-0662-0	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021087-001	TAMIFLU	OSELTAMIVIR PHOSPHATE	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS	1999-10-27
N021087-002	TAMIFLU	OSELTAMIVIR PHOSPHATE	EQ 45MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL		RLD	2007-07-02
N021087-003	TAMIFLU	OSELTAMIVIR PHOSPHATE	EQ 30MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL		RLD	2007-07-02

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N021087-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N021087-001	TAMIFLU	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS	1999-10-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021087-002	TAMIFLU	EQ 45MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL		RLD	2007-07-02	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021087-003	TAMIFLU	EQ 30MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL		RLD	2007-07-02	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021087-001	TAMIFLU	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS	1999-10-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021087-002	TAMIFLU	EQ 45MG BASE	CAPSULE / ORAL		RLD	2007-07-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021087-003	TAMIFLU	EQ 30MG BASE	CAPSULE / ORAL		RLD	2007-07-02	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021087-001	TAMIFLU	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS	1999-10-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021087-002	TAMIFLU	EQ 45MG BASE	CAPSULE / ORAL		RLD	2007-07-02	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021087-003	TAMIFLU	EQ 30MG BASE	CAPSULE / ORAL		RLD	2007-07-02	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021087-001	TAMIFLU	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS	1999-10-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021087-002	TAMIFLU	EQ 45MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021087-003	TAMIFLU	EQ 30MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021087-001	TAMIFLU	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS	1999-10-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021087-002	TAMIFLU	EQ 45MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021087-003	TAMIFLU	EQ 30MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021087-001	TAMIFLU	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS	1999-10-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021087-002	TAMIFLU	EQ 45MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021087-003	TAMIFLU	EQ 30MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021087-001	TAMIFLU	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS	1999-10-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021087-002	TAMIFLU	EQ 45MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021087-003	TAMIFLU	EQ 30MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021087-001	TAMIFLU	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS	1999-10-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021087-002	TAMIFLU	EQ 45MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021087-003	TAMIFLU	EQ 30MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021087-001	TAMIFLU	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS	1999-10-27	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021087-002	TAMIFLU	EQ 45MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021087-003	TAMIFLU	EQ 30MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021087-001	TAMIFLU	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS	1999-10-27	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021087-002	TAMIFLU	EQ 45MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021087-003	TAMIFLU	EQ 30MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021087-001	TAMIFLU	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS	1999-10-27	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021087-002	TAMIFLU	EQ 45MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021087-003	TAMIFLU	EQ 30MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021087-001	TAMIFLU	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS	1999-10-27	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021087-002	TAMIFLU	EQ 45MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021087-003	TAMIFLU	EQ 30MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021087-001	TAMIFLU	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS	1999-10-27	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021087-002	TAMIFLU	EQ 45MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021087-003	TAMIFLU	EQ 30MG BASE	CAPSULE / ORAL	AB	RLD	2007-07-02	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021087-001	TAMIFLU	EQ 75MG BASE	CAPSULE / ORAL	AB	RLD, RS	1999-10-27	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 118 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	N021087-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021087-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021087-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021087-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021087-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021087-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021087-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021087-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021087-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021087-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021087-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021087-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021087-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021087-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021087-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021087-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021087-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021087-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021087-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021087-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021087-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021087-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021087-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021087-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021087-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021087-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021087-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021087-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021087-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021087-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021087-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021087-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021087-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021087-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021087-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021087-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021087-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021087-002	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021087-003	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021087-001	AB	1	`5c6f7cd8ea54…`

Observed Orange Book exclusivity history#

Exclusivity history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021087-001	M-251	2022-08-02	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021087-002	M-251	2022-08-02	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021087-003	M-251	2022-08-02	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021087-001	M-251	2022-08-02	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021087-002	M-251	2022-08-02	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021087-003	M-251	2022-08-02	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021087-001	M-251	2022-08-02	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021087-002	M-251	2022-08-02	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021087-003	M-251	2022-08-02	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N021087-001	M-251	2022-08-02	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021087-002	M-251	2022-08-02	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021087-003	M-251	2022-08-02	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021087-001	M-251	2022-08-02	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021087-002	M-251	2022-08-02	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021087-003	M-251	2022-08-02	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021087-001	M-251	2022-08-02	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021087-002	M-251	2022-08-02	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021087-003	M-251	2022-08-02	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021087-001	M-251	2022-08-02	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021087-002	M-251	2022-08-02	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021087-003	M-251	2022-08-02	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021087-001	M-251	2022-08-02	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021087-002	M-251	2022-08-02	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021087-003	M-251	2022-08-02	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021087-001	M-251	2022-08-02	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021087-002	M-251	2022-08-02	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021087-003	M-251	2022-08-02	`c0c555d07b60…`
2023-01-26 05:58 UTC	2023-01	N021087-001	M-251	2022-08-02	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N021087-002	M-251	2022-08-02	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N021087-003	M-251	2022-08-02	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021087-001	M-251	2022-08-02	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021087-002	M-251	2022-08-02	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021087-003	M-251	2022-08-02	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021087-001	M-251	2022-08-02	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N021087-002	M-251	2022-08-02	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N021087-003	M-251	2022-08-02	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021087-001	M-251	2022-08-02	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N021087-002	M-251	2022-08-02	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N021087-003	M-251	2022-08-02	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021087-001	M-251	2022-08-02	`cb3db0bc1861…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50090-0662-0	2023-02-07	C162847	48780-1	f386c64a-253b-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use TAMIFLU safely and effectively. See full prescribing information for TAMIFLU. TAMIFLU ® (oseltamivir phosphate) capsules, for oral use TAMIFLU ® (oseltamivir phosphate) for oral suspension Initial U.S. Approval: 1999
50090-0662-0	2023-01-30	C162847	48780-1	f386c64a-253b-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use TAMIFLU safely and effectively. See full prescribing information for TAMIFLU. TAMIFLU ® (oseltamivir phosphate) capsules, for oral use TAMIFLU ® (oseltamivir phosphate) for oral suspension Initial U.S. Approval: 1999

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tamiflu	OSELTAMIVIR PHOSPHATE	Genentech, Inc.	ee3c9555-60f2-4f82-a760-11983c86e97b	2025-12-15	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021087 application number: NDA021087

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4A3O49NGEZ	OSELTAMIVIR PHOSPHATE	204255-11-8	OSELTAMIVIR PHOSPHATE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-0662-0	50090066200	1 BLISTER PACK in 1 CARTON (50090-0662-0) > 10 CAPSULE in 1 BLISTER PACK	1 blister pack	2014-11-28	0000-00-00	No	No	Current